Controlled Rewarming is Essential in Hypothermic SAH Patients
The evidence does NOT support that rapid rewarming worsens bleeding in hypothermic patients with subarachnoid hemorrhage; however, controlled slow rewarming is strongly recommended to prevent secondary brain injury and other complications. The most recent 2023 international consensus guidelines explicitly state that rewarming should be controlled at a rate of 1°C per day, not because of bleeding risk, but to minimize secondary brain injury 1.
Key Evidence on Rewarming in SAH
What the Guidelines Actually Say
The 2023 NTCR consensus guidelines (involving 19 international neurocritical care experts) achieved 100% consensus that:
- Controlled rewarming should take place at a speed of 1°C per day 1
- Normothermia should be applied in a slow and controlled fashion for as long as the brain is at risk once the patient is rewarmed 1
- Controlled but passive rewarming should be used as opposed to spontaneous, uncontrolled rewarming (94.7% consensus) 1
The 2023 AHA/ASA guidelines for aneurysmal SAH note that while hypothermia studies showed no benefit in good-grade SAH, rewarming strategies were not standardized in these trials, highlighting this as a critical variable 2.
The Real Concern: Not Bleeding, But Brain Injury
The concern with rapid rewarming is not worsening of the hemorrhage itself, but rather:
- Secondary brain injury - Rapid temperature fluctuations can exacerbate cerebral edema and metabolic stress
- Rebound effects - One study showed rapid rewarming worsened cerebral edema (85.7% vs 83.2% with slow rewarming) in intracerebral hemorrhage, though this was in an animal model 3
- Metabolic complications - Electrolyte shifts, cardiac complications, and shivering
Clinical Studies Show Safety of Controlled Rewarming
Recent clinical studies in poor-grade SAH patients using therapeutic hypothermia consistently employed slow rewarming protocols (≤1°C/day) and demonstrated:
- Improved mortality rates (20% vs 46.8% in controls) 4
- Reduced cerebral vasospasm and delayed cerebral ischemia 5, 6
- No increase in bleeding complications 5, 4
A 2025 meta-analysis of TTM in poor-grade SAH found that adverse events, including bleeding-related complications, were similar between hypothermia and control groups 7.
Practical Management Algorithm
For a hypothermic patient with SAH:
- Secure the aneurysm first - Address the bleeding source before temperature management decisions
- Monitor core temperature continuously - Bladder, esophageal, or rectal temperature 1
- Target normothermia (36.0-37.5°C) once aneurysm is secured 1
- Rewarm at ≤1°C per day using automated feedback-controlled devices 1
- Maintain normothermia with temperature variation <0.5°C/hour and <1°C/24 hours 1
- Manage shivering aggressively during rewarming to prevent secondary injury 1
Critical Pitfalls to Avoid
- Do not rapidly rewarm - Even though bleeding risk is not the primary concern, rapid rewarming can worsen cerebral edema and metabolic derangements
- Do not assume hypothermia is protective - The IHAST trial showed no benefit of intraoperative hypothermia in good-grade SAH 2
- Do not use uncontrolled passive rewarming - Active temperature management with automated devices is preferred 1
Bottom Line
There is no high-quality evidence that rapid rewarming increases bleeding in SAH patients. The recommendation for slow, controlled rewarming (1°C/day) is based on preventing secondary brain injury, metabolic complications, and cerebral edema—not hemorrhage expansion. This represents expert consensus from the most recent (2023) international guidelines 1.